Astellas Accused Of Delaying Generic Drug Approval
By Dan Rivoli ( September 14, 2011, 9:50 PM EDT) -- Astellas Pharma US Inc. was hit with a putative class action by a union benefit fund Wednesday in Massachusetts federal court for allegedly keeping a generic version of its immune-suppressing drug off the market and jacking up indirect purchasers' costs....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.